FDA Errs On Estimates For NDIs, Claims Substantiation – CRN
This article was originally published in The Tan Sheet
Executive Summary
FDA “grossly underestimated” firms’ costs for filing new dietary ingredient notifications and ignored their costs for substantiating claims, the Council for Responsible Nutrition says in July 25 comments.